HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the article, please login or register as reader.

2018

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 5 - 6)

Treatment Expansion for Opioid Use Disorders in the United States

Parrino M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 7 - 12)

Capgras Syndrome in a Heroin Addict. A Case Study

Lovrecic M., and Lovrecic B.

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 13 - 20)

Opioid Maintenance Therapy with Methadone and Levomethadone - Sexual Dysfunction and Treatment Satisfaction

Schoofs N., Häbel T.H., Bermpohl F., and Gutwinski S.

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 21 - 30)

On the Long-Term Status of Treatment-Seeking, Heroin Addicted Patients: A 22-Year Follow-up Study on Mortality and Drug Use in Portugal

Pombo S., and Félix da Costa N.

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 31 - 36)

Methadone Versus Torture: The Perspective of the European Court of Human Rights

Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O.

Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 37 - 44)

Characteristics of Methadone-Related Overdose Deaths and Comparisons between Those Dying on and Off Opioid Agonist Treatment (OAT): a National Cohort Study.

Van Hout M.C., Crowley D., Collins C., Barry A., Lyons S., and Delargy I.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 5 - 11)

Methadone Dose as a Determinant of Infant Outcome During the Peri and Postnatal Period

Wang M., Stapleton J., and Wolff K.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 13 - 22)

Affective Temperaments in Non-Depressed Patients with Alcohol and Opiate Addictions. Is the “Dark Side” Associated with Current Depressive Symptoms?

Kałwa A., Siwy-Hudowska A., and Niznikiewicz M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 23 - 29)

Heroin Deaths in Norway in 2000 and 2009: A Comparative Study of Polydrug Use

Karinen R., Konstantinova-Larsen S., Normann P.T., Mørland J., Christophersen A.S., and Arnestad M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 31 - 33)

Refractory Bipolar Patient Treated with Oral Methadone: Does Methadone Act as Mood Stabilizer?

Etaee F., Shirdel S., Azarhomayoun A., Nasiri K., and Komaki A.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 35 - 40)

Excess Suicide Mortality in Heroin Use Disorder Patients Seeking Opioid Agonist Treatment in Slovenia and Risk Factors for Suicide

Lovrecic M., Lovrecic B., Maremmani I., and Maremmani A.G.I.

Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 41 - 50)

How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 5: Higher Dosage

Ulmer A., and Meinhold C.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 5 - 12)

The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder

Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 13 - 24)

Novel Psychoactive Synthetic Cannabinoids and Synthetic Cathinones: The Never-Ending Story of Potential Clinical Toxicity

Lovrecic B., and Lovrecic M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 25 - 32)

Relationship between Self-Mutilative Behaviour and Novelty Seeking, the Presence of Antisocial and Borderline Personality Disorders, and Severity of Psychopathology in a Sample of Male Patients with Heroin Use Disorder

Evren C., Karabulut V., Alniak I., Umut G., Cetin T., Evren B., and Agachanli R.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 33 - 40)

Impact of Employment and Marital Status on Lapse Risk Situations among Addicted Patients in Methadone Maintenance Treatment

Abed M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 41 - 49)

How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting

Staub L., Gerber M., Vogel M., Dürsteler-Macfarland K., Strom J., Schoen S., Pühse U., and Colledge F.

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 51 - 58)

Diversion of Buprenorphine: Scope of the Problem and the Measures Taken to Address It

Tripathi R., and Sarkar S.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 5 - 11)

Multidisciplinary Settings in the Treatment of Drug-Addiction: An Experimental Evaluation

Cicatelli P., Borriello M.T., De Vivo C., D'Oriano V., Fuscone A., Moccia E., and Siconolfi M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 13 - 18)

A Review of Literature Assessing Public Opinion of Heroin Assisted Treatment

Berrigan P.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 19 - 28)

Predictors of Retention and Mortality among Patients on Methadone Maintenance Therapy

Teoh J., Yee A., and Danaee M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 29 - 35)

Impact of Hepatitis B(Hbv)/C(Hcv) Virus Co-Infection on the Long-Term Survival of Patients with Schizophrenia and Co-Occurring Substance Use Disorders

Gimelfarb Y., Ligay A., and Ben Tzarfati M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 37 - 43)

The Cost-Effectiveness of Naloxone Programmes for the Treatment of Heroin Overdoses ‘on the Street': A 2-Year Data Collection by the Street Unit of the Villa Maraini Foundation

Barra M., Direnzo G.F.M., Patruno F.V., Patti M., Rodoquino G., Rossi E., Santoro R., and Badiani A.

Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 45 - 54)

Personality Profiles and Aggressive Behaviour of Heroin Use Disorder Patients Compared with Non-Substance-Use Peers

Conversano C., Belcari I., Marchi L., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 5 - 11)

Addiction and self-reported associated sociodemographic factors in a small province of Iran

Sedaghat Z., Fararouei M., Shahraki G., Karimzadeh Shirazi K., and Haghighi R.E.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 13 - 17)

An evaluation of community pharmacist perception of the misuse and abuse of over-the-counter co-codamol in Cornwell and Devon, UK: a cross-sectional survey

Barrett R., and Costa D.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 19 - 28)

Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study

Reed K., Knight A., Baillie S., Bogdanowicz K., Bell J., and Strang J.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 29 - 34)

The SCL90-Based psychopathological structure may be applied in substance use disorder patients independently of the drug involved, even in heroin, alcohol and cocaine monodrug users

Carbone M.G., Maiello M., Spera V., Manni C., Pallucchini A., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 35 - 49)

Comparing neurocognitive function in individuals receiving chronic methadone or buprenorphine for the treatment of opioid dependence: A systematic review.

Hill D., Garner D., and Baldacchino A.

Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 50 - 53)

Medicinal products detected as novel psychoactive substances: The case of intravenous use of tropicamide.

van Hout M.C.

Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 5 - 15)

The Pros and Cons of Supervised Urine Tests in Opioid Maintenance Treatment: A Study of Patients' Experiences

Monwell B., Bülow P., and Johnsson B.

Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 17 - 25)

‘You Should Be Helping Him, He's Trying to Do Something About It': The Dilemma of Heroin Use, Agonist Opioid Treatment and Employment

Emmerson O., Parkman T., Akhtar S., Lowe E., and Day E.

Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 27 - 34)

Sleep Problems among Intravenous and Non-Intravenous Opioid-Dependent Patients: The Role of Modality of Use

Khazaie H., Jalali A., Cheraghi K., Mojtaba Ahmadi S., and Khaledi-Paveh B.

Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 35 - 37)

Outbreak of 'Novel Synthetic Opioids': A Deadly Threat to Public Health

Lovrecic B., and Lovrecic M.

Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 39 - 50)

Personality Dimensions and Main Drug of Use in Dual Disorders

Hurtado Ruiz M.G., Fonseca F., Díaz Digón L., Martínez Riera R., Martínez Sanvisens D., Mateu Codina G.A., Farre Martínez A., Sauras Quetcuti R.B., and Torrens M.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page